Forte Biosciences Net Worth
Forte Biosciences Net Worth Breakdown | FBRX |
Forte Biosciences Net Worth Analysis
Forte Biosciences' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Forte Biosciences' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Forte Biosciences' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Forte Biosciences' net worth analysis. One common approach is to calculate Forte Biosciences' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Forte Biosciences' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Forte Biosciences' net worth. This approach calculates the present value of Forte Biosciences' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Forte Biosciences' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Forte Biosciences' net worth. This involves comparing Forte Biosciences' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Forte Biosciences' net worth relative to its peers.
Enterprise Value |
|
To determine if Forte Biosciences is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Forte Biosciences' net worth research are outlined below:
| Forte Biosciences is way too risky over 90 days horizon | |
| Forte Biosciences appears to be risky and price may revert if volatility continues | |
| Forte Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (31.48 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Forte Biosciences currently holds about 38.55 M in cash with (28.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.89. | |
| Forte Biosciences has a poor financial position based on the latest SEC disclosures | |
| Latest headline from benzinga.com: Forte Biosciences Shares Are Soaring Today Whats Going On |
Forte Biosciences uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Forte Biosciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Forte Biosciences' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Forte Biosciences' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Forte Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Forte Biosciences backward and forwards among themselves. Forte Biosciences' institutional investor refers to the entity that pools money to purchase Forte Biosciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | State Street Corp | 2024-06-30 | 37.6 K | Susquehanna International Group, Llp | 2024-06-30 | 34.3 K | Vanguard Group Inc | 2024-09-30 | 26.4 K | Ubs Group Ag | 2024-06-30 | 24.3 K | Goldman Sachs Group Inc | 2024-06-30 | 20.8 K | Tower Research Capital Llc | 2024-06-30 | 15.8 K | Group One Trading, Lp | 2024-06-30 | 14 K | Hsbc Holdings Plc | 2024-06-30 | 10.7 K | Citadel Advisors Llc | 2024-06-30 | 8.1 K | Tybourne Capital Management (hk) Ltd | 2024-06-30 | 3.6 M | Cable Car Capital Llc | 2024-06-30 | 2 M |
Follow Forte Biosciences' market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 22.86 M.Market Cap |
|
Project Forte Biosciences' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.81) | (0.85) | |
| Return On Capital Employed | (0.92) | (0.87) | |
| Return On Assets | (0.81) | (0.85) | |
| Return On Equity | (0.89) | (0.94) |
When accessing Forte Biosciences' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Forte Biosciences' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Forte Biosciences' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Forte Biosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Forte Biosciences. Check Forte Biosciences' Beneish M Score to see the likelihood of Forte Biosciences' management manipulating its earnings.
Evaluate Forte Biosciences' management efficiency
Forte Biosciences has return on total asset (ROA) of (0.8125) % which means that it has lost $0.8125 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.7091) %, meaning that it created substantial loss on money invested by shareholders. Forte Biosciences' management efficiency ratios could be used to measure how well Forte Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.85 in 2024. Return On Capital Employed is likely to rise to -0.87 in 2024. At this time, Forte Biosciences' Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 831.9 K in 2024, whereas Non Current Assets Total are likely to drop slightly above 620.4 K in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 27.96 | 26.57 | |
| Tangible Book Value Per Share | 27.96 | 26.57 | |
| Enterprise Value Over EBITDA | (0.43) | (0.45) | |
| Price Book Value Ratio | 0.73 | 0.70 | |
| Enterprise Value Multiple | (0.43) | (0.45) | |
| Price Fair Value | 0.73 | 0.70 | |
| Enterprise Value | 16.1 M | 15.3 M |
The strategic initiatives led by Forte Biosciences' management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Return On Equity (1.71) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Forte Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Forte Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Forte Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Forte Biosciences Corporate Filings
8K | 20th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 2nd of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 19th of September 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Forte Biosciences Earnings per Share Projection vs Actual
Additional Tools for Forte Stock Analysis
When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.